U.S. Transrectal Ultrasound Market 2025-2033 Analysis: Trends, Competitor Dynamics, and Growth Opportunities

Key Insights

The U.S. Transrectal Ultrasound Market size was valued at USD 31,763 Million in 2023 and is projected to reach USD 68,234 Million by 2032, exhibiting a CAGR of 8.4 % during the forecast period. Transrectal Ultrasound or TRUS is one of the diagnostic imaging techniques that is typically applied for the evaluation of the prostate. An ultrasound probe must be inserted in the rectum, and by using high-frequency sound waves, pictures of the prostate structure and tissues are produced. TRUS comes in two main types: Diagnostic TRUS specifically used for the assessment of the prostate gland and biopsy, and therapeutic TRUS which is used in procedures such as brachytherapy. Some of the benefits of TRUS include allowing real-time imaging, high-resolution images, and the use of needle biopsies. They are commonly used in demarcating conditions such as prostate cancer, benign prostatic hyperplasia, and prostatitis. TRUS also helps in the treatment of prostate-related issues and planning surgeries. The advantages of TRUS include a non-invasive approach with a short time for recuperation, sensitivity and specificity in localized prostate cancer diagnosis. It also provides real-time imaging that increases the biopsy accuracy and minimises sampling errors to facilitate adequate strategies in treatment.

U.S. Transrectal Ultrasound Trends

• Growing adoption of artificial intelligence (AI) and machine learning (ML) in transrectal ultrasound devices
• Increasing use of transrectal ultrasound in image-guided prostate biopsies and treatments
• Growing preference for portable transrectal ultrasound systems due to their convenience and affordability

Driving Forces: What's Propelling the U.S. Transrectal Ultrasound Market

• Rising prevalence of prostate cancer: Prostate cancer is the most common cancer among men in the U.S. Transrectal ultrasound is a vital tool for prostate cancer screening, diagnosis, and treatment.
• Technological advancements: Transrectal ultrasound systems have undergone significant advancements, such as the introduction of high-resolution probes, 3D imaging capabilities, and AI-assisted image analysis. These advancements enable more accurate and comprehensive imaging of the prostate.
• Increasing demand for minimally invasive imaging techniques: Transrectal ultrasound is a non-invasive imaging technique that provides real-time images of the prostate. This reduces discomfort and recovery time for patients compared to other imaging methods.

Challenges and Restraints in the U.S. Transrectal Ultrasound Market

• Lack of awareness about transrectal ultrasound: Some patients may be unaware of the benefits of transrectal ultrasound and may hesitate to undergo the procedure.
• Cost of transrectal ultrasound: Transrectal ultrasound systems can be expensive, which may limit their accessibility in certain settings.
• Adverse effects: Transrectal ultrasound may cause discomfort or pain in some patients, especially during biopsy or treatment procedures.

Emerging Trends in U.S. Transrectal Ultrasound

• AI-assisted image analysis: AI algorithms can assist in interpreting transrectal ultrasound images, improving diagnostic accuracy and efficiency.
• Fusion imaging: The integration of transrectal ultrasound with other imaging modalities, such as MRI, is gaining traction, providing more comprehensive information for prostate cancer diagnosis and treatment.
• Robotic-assisted transrectal ultrasound: Robotic systems can enhance the precision and consistency of transrectal ultrasound procedures, reducing operator dependency and improving patient outcomes.

Growth Catalysts in U.S. Transrectal Ultrasound Industry

• Increased Investment in Prostate Cancer Research and Development: Significant funding from government agencies (such as the NIH) and private institutions fuels innovation in prostate cancer diagnostics and treatment. This includes advancements in transrectal ultrasound technology, leading to improved image quality, faster scan times, and enhanced diagnostic capabilities. Focus areas include fusion biopsy techniques and the development of AI-powered image analysis tools.
• Expanding Prostate Cancer Screening Initiatives and Awareness Campaigns: Public health initiatives aimed at raising awareness about prostate cancer risk factors and promoting early detection are driving increased demand for transrectal ultrasound. These initiatives often include targeted outreach to high-risk populations and improved access to screening services.
• Rising Adoption of Personalized and Precision Oncology: Transrectal ultrasound is integral to personalized prostate cancer management. It facilitates accurate biopsy targeting for improved diagnostic precision, enabling more effective treatment selection (e.g., active surveillance, radiation therapy, surgery) based on individual patient characteristics. Furthermore, it aids in monitoring treatment response and detecting recurrence.
• Technological Advancements in Transrectal Ultrasound Systems: The market is witnessing continuous innovation, with the introduction of higher-resolution probes, 3D/4D imaging capabilities, and fusion imaging technologies that integrate ultrasound with other imaging modalities (such as MRI) for superior visualization and improved diagnostic accuracy. This drives adoption among healthcare providers.
• Aging Population and Increased Prevalence of Prostate Cancer: The increasing incidence of prostate cancer, coupled with a growing aging population in the U.S., contributes to the expanding demand for transrectal ultrasound services. This demographic trend fuels the need for robust and efficient diagnostic tools.

Market Segmentation: U.S. Transrectal Ultrasound Analysis

Product:

• Systems
• Transducers

Type:

• Cart/Trolley-Based
• Portable

Application:

• Diagnostic
• Prostate Cancer
• Benign Prostatic Hyperplasia
• Others
• Image-guided Treatment

End-user:

• Hospitals & ASCs
• Diagnostic Centers
• Others

Leading Players in the U.S. Transrectal Ultrasound Market

• KOELIS (Germany)
• GE HealthCare (U.S.)
• Exact Imaging (Canada)
• FUJIFILM Corporation (Japan)
• Strata Imaging (U.S.)
• HALO Medical Technologies (U.S.)
• GEOTEK (U.K.)
• Koninklijke Philips N.V. (Netherlands)

Significant Developments in the U.S. Transrectal Ultrasound Sector

• February 2023: GE HealthCare acquires Caption Health, an AI healthcare leader, to enhance ultrasound imaging capabilities.
• April 2022: KOELIS secures USD 10.5 million in growth equity financing to expand its prostate cancer diagnosis and treatment portfolio.
• July 2020: KOELIS receives VA approval for government customers to provide prostate MRI fusion through the Trinity 3D Prostate Suite.

Comprehensive Coverage U.S. Transrectal Ultrasound Market Report

Our comprehensive report offers detailed insights on the U.S. transrectal ultrasound market, including:

• Market Size and Forecast: A precise quantification of the current market value and projected growth trajectory, segmented by key parameters.
• Detailed Market Segmentation: Comprehensive analysis of the market categorized by product type (e.g., probes, systems, software), application (e.g., biopsy guidance, staging), end-user (e.g., hospitals, clinics, ambulatory surgical centers), and technology.
• Competitive Landscape Analysis: In-depth profiles of key players, assessing their market share, strategies, competitive advantages, and recent developments.
• Key Industry Trends and Drivers: Identification and analysis of crucial factors shaping market dynamics, including technological advancements, regulatory changes, reimbursement policies, and economic conditions.
• Growth Opportunities and Challenges: Exploration of potential avenues for expansion and identification of obstacles that may impede market growth.
• Future Outlook and Projections: A forward-looking perspective on the market's trajectory, considering emerging trends and their potential impact.

Regional Insight

The U.S. remains the dominant market for transrectal ultrasound, propelled by the high prevalence of prostate cancer and the widespread adoption of advanced healthcare technologies. The market is expected to continue its upward trajectory, driven by factors such as:

• Increasing awareness and early detection of prostate cancer
• Technological advancements in ultrasound imaging, such as high-resolution imaging and 3D reconstruction
• The use of transrectal ultrasound as a guidance tool for prostate biopsy and other procedures
• Government initiatives aimed at reducing prostate cancer mortality

• Europe: Growing awareness of prostate cancer and the implementation of screening programs in several countries
• Asia-Pacific: Increasing healthcare expenditure and a rising incidence of prostate cancer in aging populations
• Latin America: Expanding access to healthcare and the establishment of specialized prostate cancer treatment centers

DROCT

• Comprehensive market data and insights
• In-depth analysis of market dynamics
• Future market outlook and growth projections
• Competitive analysis of leading players
• Exhaustive coverage of industry trends

Pricing Analysis

Competitive pricing strategies are adopted by market participants to gain market share. The pricing of transrectal ultrasound systems varies depending on factors such as features, brand reputation, and geographical location.

Import And Export Analysis

The U.S. imports and exports transrectal ultrasound systems and components. Imports are primarily from countries like Germany, Japan, and Canada, while exports are mainly to developing countries in Asia-Pacific and Latin America.

Segmentation

The U.S. transrectal ultrasound market is segmented by product, type, application (Benign Prostatic Hyperplasia), and end-user. Each segment is analyzed in detail to provide a comprehensive understanding of the market.

Patent/Trademark Analysis

Patents and trademarks play a significant role in the development and commercialization of transrectal ultrasound devices. Our report includes an analysis of key patents and trademarks in the market.